Literature DB >> 2438036

A rapid in vitro assay for quantitating the invasive potential of tumor cells.

A Albini, Y Iwamoto, H K Kleinman, G R Martin, S A Aaronson, J M Kozlowski, R N McEwan.   

Abstract

We have reconstituted a matrix of basement membrane onto a filter in a Boyden chamber and assessed the ability of various malignant and nonmalignant cells to penetrate through the coated filter. Cells from all the malignant cell lines tested were able to cross the matrix in 5-6 h, whereas human fibroblasts as well as mouse 3T3 and 10T1/2 cell lines, which are not tumorigenic, were not invasive. In addition, normal primary prostate epithelial cells and benign prostatic hyperplasia cells were not invasive when tested in this assay, whereas malignant prostate carcinoma cells were highly invasive. Parallel experiments with these prostatic cells using the intrasplenic assay for metastasis detection in the nude mouse confirmed the benign behavior of the former cells and the metastatic phenotype of the latter ones. These results suggest that this in vitro test allows the rapid and quantitative assessment of invasiveness and a means to screen for drugs which alter the invasive phenotype of tumor cells.

Entities:  

Mesh:

Year:  1987        PMID: 2438036

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  487 in total

1.  A modified Boyden chamber assay for tumor cell transendothelial migration in vitro.

Authors:  Y H Li; C Zhu
Journal:  Clin Exp Metastasis       Date:  1999-07       Impact factor: 5.150

2.  Effects of Taxotere on invasive potential and multidrug resistance phenotype in pancreatic carcinoma cell line SUIT-2.

Authors:  B Liu; E Staren; T Iwamura; H Appert; J Howard
Journal:  World J Gastroenterol       Date:  2001-02       Impact factor: 5.742

3.  Identification of an invasive, N-cadherin-expressing epithelial cell type in endometriosis using a new cell culture model.

Authors:  A Zeitvogel; R Baumann; A Starzinski-Powitz
Journal:  Am J Pathol       Date:  2001-11       Impact factor: 4.307

4.  Direct binding of occupied urokinase receptor (uPAR) to LDL receptor-related protein is required for endocytosis of uPAR and regulation of cell surface urokinase activity.

Authors:  R P Czekay; T A Kuemmel; R A Orlando; M G Farquhar
Journal:  Mol Biol Cell       Date:  2001-05       Impact factor: 4.138

5.  CD166/activated leukocyte cell adhesion molecule is expressed on glioblastoma progenitor cells and involved in the regulation of tumor cell invasion.

Authors:  Noriyuki Kijima; Naoki Hosen; Naoki Kagawa; Naoya Hashimoto; Akiko Nakano; Yasunori Fujimoto; Manabu Kinoshita; Haruo Sugiyama; Toshiki Yoshimine
Journal:  Neuro Oncol       Date:  2011-12-13       Impact factor: 12.300

6.  Imaging prostate cancer invasion with multi-nuclear magnetic resonance methods: the Metabolic Boyden Chamber.

Authors:  U Pilatus; E Ackerstaff; D Artemov; N Mori; R J Gillies; Z M Bhujwalla
Journal:  Neoplasia       Date:  2000 May-Jun       Impact factor: 5.715

7.  The transcription factor snail mediates epithelial to mesenchymal transitions by repression of estrogen receptor-alpha.

Authors:  Archana Dhasarathy; Masahiro Kajita; Paul A Wade
Journal:  Mol Endocrinol       Date:  2007-08-30

8.  Multi-Domain Photopatterned 3D Tumor Constructs in a Micro-Physiological System for Analysis, Quantification, and Isolation of Infiltrating Cells.

Authors:  Shiny A P Rajan; Aleksander Skardal; Adam R Hall
Journal:  Adv Biosyst       Date:  2020-02-25

9.  The in vitro invasiveness and interactions with laminin of K-1735 melanoma cells. Evidence for different laminin-binding affinities in high and low metastatic variants.

Authors:  A Albini; S L Aukerman; R C Ogle; D M Noonan; R Fridman; G R Martin; I J Fidler
Journal:  Clin Exp Metastasis       Date:  1989 Jul-Aug       Impact factor: 5.150

10.  Malignant melanoma metastasis to brain: role of degradative enzymes and responses to paracrine growth factors.

Authors:  G L Nicolson; M Nakajima; J L Herrmann; D G Menter; P G Cavanaugh; J S Park; D Marchetti
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.